Edward Lung, MD
- ASSOCIATE PROFESSOR | Medicine, Gastroenterology
Dr. Lung also has a Masters of Public Health from University of California, Berkeley.
American Board of Internal Medicine
MD, UMDNJ Robert Wood Johnson Medical School
Residency, Internal Medicine, NYU Medical Center
Fellowship, Gastroenterology, University of California - San Francisco
Honors • 2004 Academic Skills Workshop Participant, American Gastroenterological Association • 2003 Cancer Research and Prevention Foundation Fellowship Award • 2001 American College of Gastroenterology Clinical Research Award • 1992 NIH Summer Student Fellowship • 1990 Horace W. Stunkard Prize, New York University • 1986-1990 College of Arts and Science Scholar, New York University • 1986-1990 Dean’s Fellow, New York University
1. Pancreatic Cancer
2. Esophageal Cancer
3. Colon Cancer
4. Gastroesophageal Reflux Disease
5. Therapeutic Endoscopy
8. Enteral Stenting
Siba Y, Gorantla S, Gupta A, Lung E, Culpepper-Morgan J. Esophageal intramural pseudodiverticulosis, a rare cause of food impaction: case report and review of the literature. Gastroenterology report 2015 May; 3(2).
Velayos FS, Williamson A, Sousa KH, Lung E, Bostrom A, Weber EJ, Ostroff JW, Terdiman JP. Early predictors of severe lower gastrointestinal bleeding and adverse outcomes: a prospective study. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2004 Jun; 2(6).
Teng A, Haas C, Lee DY, Wang J, Lung E, Attiyeh F. Primary lymph node gastrinoma. A diagnosis of exclusion. A case for duodenotomy in the setting of a negative imaging for primary tumor: A case report and review of the literature. International journal of surgery case reports 2014 Oct; 5(11).
Lung E. Diagnosis of Irritable Bowel Syndrome. The Gastroenterology Fellow 2003;2:2-9..;.
Lung E. Evaluation and Management of Gastrointestinal Bleeding, Part One: Upper GI Bleeding. Advanced Studies in Medicine. 2004;4(4):186-190..;.
Lung E. Evaluation and Management of Gastrointestinal Bleeding, Part Two: Lower GI Bleeding and Obscure GI Bleeding. Advanced Studies in Medicine. 2004;4(5):245-250..;.
Lung E. Acute Diarrheal Diseases. In Current Diagnosis & Treatment In Gastroenterology, 2nd edition. Edited by Grendell JH, McQuaid KR, and Friedman SL..;.
Lung E, Levin TR, Habel L, Corley D. Prevalence of gastric metaplasia without intestinal metaplasia among patients with adenocarcinoma of the esophagus. Gastrointestinal Endoscopy 2001;53:AB146. Presented at Digestive Disease Week, May 2001..;.
Velayos FS, Lung E, Bostrom A, Weber E, Ostroff JW, Terdiman JP. Early predictors of significant lower intestinal bleeding and adverse events: A prospective study. Presented at the 68th Annual Scientific Meeting of the American College of Gastroenterology, October, 2003..;.
Lung E, . The Effect of Rofecoxib on Cyclooxygenase-2 Expression, Prostaglandin E2 Content, and Cell Proliferation in Barrett’s Esophagus. Presented at American Gastroenterological Association Poster Session, Digestive Disease Week, May 2004..;.